These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 732728)

  • 1. Emergency treatment of severe hypertension with intravenous labetalol.
    McGrath BP; Matthews PG; Walter NM; Maydom BW; Johnston CI
    Med J Aust; 1978 Oct; 2(9):410-1. PubMed ID: 732728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.
    Cummings AM; Brown JJ; Fraser R; Lever AF; Morton JJ; Richards DA; Robertson JI
    Br J Clin Pharmacol; 1979 Oct; 8(4):359-64. PubMed ID: 508511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severe hypertension by repeated bolus injections of labetalol.
    Cumming AM; Brown JJ; Lever AF; Mackay A; Robertson JI
    Br J Clin Pharmacol; 1979; 8(Suppl 2):199S-204S. PubMed ID: 393288
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous labetalol in severe hypertension. Effects on blood pressure, plasma renin activity and catecholamines.
    Lechi A; Picotti GB; Covi G; Pomari S; Pedrolli E; Cesura AM; Danti G; Mattioli M
    Arzneimittelforschung; 1981; 31(3):524-6. PubMed ID: 7013770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intravenous labetalol on blood pressure, angiotensin II and aldosterone in hypertension: comparison with propranolol.
    Rosei EA; Trust PM; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI
    Clin Sci Mol Med Suppl; 1976 Dec; 3():497s-499s. PubMed ID: 1071671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
    Martinand A; Lardoux H; Corvol P; Milliez P
    Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effects of labetalol, bendrofluazide and their combination in hypertension.
    Dawson A; Johnson BF; Smith IK; Munro-Faure AD
    Br J Clin Pharmacol; 1979 Aug; 8(2):149-54. PubMed ID: 385023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of increasing doses of labetalol on blood pressure, plasma renin activity and aldosterone in hypertensive patients.
    Salvetti A; Pedrinelli R; Sassano P; Arzilli F
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():401s-404s. PubMed ID: 396086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
    Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI; Trust PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):83-8. PubMed ID: 14627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Labetalol in essential hypertension.
    Larochelle P; Hamet P; Hoffman B; Kuchel O; McKenzie J; Mitenko P; Ogilvie RI; Ruedy J
    J Cardiovasc Pharmacol; 1980; 2(6):751-9. PubMed ID: 6160325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous labetalol in the management of severe hypertension and hypertensive emergencies.
    Cressman MD; Vidt DG; Gifford RW; Moore WS; Wilson DJ
    Am Heart J; 1984 May; 107(5 Pt 1):980-5. PubMed ID: 6720529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.
    Trust PM; Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):799-803. PubMed ID: 791333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: Intravenous labetalol in severe hypertension.
    Rosei EA; Trust PM; Brown JJ; Lever AF; Robertson JI
    Lancet; 1975 Nov; 2(7944):1093-4. PubMed ID: 53581
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.
    Hauger-Klevene JH
    Pharmatherapeutica; 1981; 3(1):46-54. PubMed ID: 7033992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive effectiveness of intravenous labetalol in accelerated hypertension.
    Smith WB; Clifton GG; O'Neill WM; Wallin JD
    Hypertension; 1983; 5(4):579-83. PubMed ID: 6862581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Labetalol infusion in hypertensive emergencies.
    Lebel M; Langlois S; Belleau LJ; Grose JH
    Clin Pharmacol Ther; 1985 Jun; 37(6):615-8. PubMed ID: 3891186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute management of severe hypertension with oral labetalol.
    Ghose RR
    Br J Clin Pharmacol; 1979; 8(Suppl 2):189S-193S. PubMed ID: 526400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies.
    Wilson DJ; Wallin JD; Vlachakis ND; Freis ED; Vidt DG; Michelson EL; Langford HG; Flamenbaum W; Poland MP
    Am J Med; 1983 Oct; 75(4A):95-102. PubMed ID: 6139020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labetalol in the treatment of severe essential hypertension: relationship between arterial blood pressure, plasma catecholamines, plasma renin activity, plasma aldosterone and body weight.
    Kornerup HJ; Pedersen EB; Christensen NJ; Pedersen A; Pedersen G
    Acta Med Scand Suppl; 1979; 625():59-64. PubMed ID: 34981
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.